Ignite Creation Date:
2024-05-06 @ 1:01 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03910712
Status:
UNKNOWN
Last Update Posted:
2019-04-10
First Post:
2019-04-03
Brief Title:
Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive HR Positive MBC
Sponsor:
Peking Union Medical College Hospital
Organization:
Peking Union Medical College Hospital
Organization Data
Organization:
Peking Union Medical College Hospital
Class:
OTHER
Study ID:
BREAST-Pyrotinib
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking Union Medical College Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Qiang SUN
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Peking Union Medical College Hospital
Old Name:
None
Old Organization:
None